Document Detail

Pharmacotherapy of Alzheimer's disease: current and future trends.
MedLine Citation:
PMID:  25481975     Owner:  NLM     Status:  Publisher    
Alzheimer's disease (AD) and its related dementia has shown an alarming rise in the global population. Although considerable efforts have been made to develop effective therapeutic agents for AD therapy, drug development has not met significant clinical success. Current pharmacotherapy of AD is limited to cholinesterase inhibitors and the N-methyl-D-aspartate antagonist memantine. Considerable research is underway to develop newer agents for the management of AD. Since amyloid-β (Aβ) has been implicated in AD pathogenesis, the use of β secretase inhibitors as well as immunotherapy against Aβ has been investigated. A considerable effort has been spent investigating the therapeutic potential of antioxidants and anti-inflammatory agents, several of natural products and dietary origin, in AD treatment. Numerous drug targets have also been investigated for AD treatment and a modest drug pipeline is available. Despite these efforts, drug development for AD has proved extremely difficult and most clinical trials have afforded disappointing results.
Werner J Geldenhuys; Altaf S Darvesh
Related Documents :
25267345 - Advances in oral controlled drug delivery: the role of drug-polymer and interpolymer no...
23649995 - Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydrox...
21453255 - Mucoadhesive patches of salbutamol sulphate for unidirectional buccal drug delivery: de...
23142475 - Pharmacokinetic drivers of toxicity for basic molecules: strategy to lower pka results ...
24819645 - Histopathological and immunohistochemical features of drug-induced exanthems.
22692675 - Drug-associated blood cell dyscrasias.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-8
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  -     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-8     Completed Date:  -     Revised Date:  2014-12-9    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-3     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mortality and causes of death of Dutch burn patients during the period 2006-2011.
Next Document:  DEBATE: Should Dialysis at Home be Mandatory for All Suitable ESRD Patients?: Home-Based Dialysis Th...